Literature DB >> 32129891

Motor unit number index in quantitatively assessing motor root lesions and monitoring treatment outcomes in patients with lumbosacral radiculopathy.

Chaojun Zheng1, Zhenhao Chen1, Yu Zhu2, Feizhou Lyu1,3, Xiaosheng Ma1, Robert Weber2, Dong Tian4, Jianyuan Jiang1, Xinlei Xia1.   

Abstract

INTRODUCTION: We investigated the feasibility of motor unit number index (MUNIX) in quantitatively assessing motor root lesions and tracking different treatment outcomes in lumbosacral radiculopathy (LR).
METHODS: Bilateral MUNIX was recorded from the abductor hallucis, extensor digitorum brevis, and tibialis anterior in 44 normal controls and 108 patients with LR, and this was repeated approximately 12 months after treatment in 60 patients with LR.
RESULTS: More abnormalities were observed when side-to-side differences of MUNIX measurements were used to evaluate LR (P < .05). Motor unit number index measurements worsened without progression of muscle weakness after conservative treatment, and MUNIX measurements improved with or without increased muscle strength after surgical treatment (P < .05). DISCUSSION: Motor unit number index may identify a specific L5 or S1 motor root lesion even before muscle weakness occurs, especially when side-to-side differences are used. Changes in MUNIX were larger than those in motor function measures after treatments for LR.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  lumbosacral radiculopathies; motor root lesions; motor unit number index; quantitative assessment; side-to-side differences; treatment outcome

Year:  2020        PMID: 32129891     DOI: 10.1002/mus.26854

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  1 in total

1.  Motor unit number index detects the effectiveness of surgical treatment in improving distal motor neuron loss in patients with incomplete cervical spinal cord injury.

Authors:  Jun Li; Yancheng Zhu; Yang Li; Shisheng He; Deguo Wang
Journal:  BMC Musculoskelet Disord       Date:  2020-08-15       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.